Occurrence mutations in the BRCA1 and BRCA2 genes in the Czech Republic can be estimated at 2.8% based on the occurrence of population-specific variants in an unselected population of women with breast cancer [12]. The gene discussed is BRCA1; the disease is breast carcinoma.